Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Demographic and Viral-Genetic Analyses of COVID-19 Severity in Bahrain Identify Local Risk Factors and a Protective Effect of Polymerase Mutations

View ORCID ProfileEvan M. Koch, Justin Du, Michelle Dressner, Hashmeya Erahim Alwasti, Zahra Al Taif, Fatima Shehab, Afaf Merza Mohamed, Amjad Ghanem, Alireza Haghighi, Shamil Sunyaev, Maha Farhat
doi: https://doi.org/10.1101/2022.08.13.22278740
Evan M. Koch
1Department of Biomedical Informatics, Harvard Medical School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evan M. Koch
Justin Du
2Yale University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Dressner
3Harvard T.H. Chan School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hashmeya Erahim Alwasti
4Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahra Al Taif
4Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fatima Shehab
4Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afaf Merza Mohamed
4Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amjad Ghanem
4Public Health Laboratories, Public Health Directorate, Bahrain Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alireza Haghighi
5Division of Genetics, Department of Medicine, Brigham and Women’s Hospital
6Department of Genetics, Harvard Medical School
7Broad Institute of MIT and Harvard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maha_farhat@hms.harvard.edu ahaghighi@bwh.harvard.edu
Shamil Sunyaev
1Department of Biomedical Informatics, Harvard Medical School
5Division of Genetics, Department of Medicine, Brigham and Women’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maha Farhat
1Department of Biomedical Informatics, Harvard Medical School
8Pulmonary and Critical Care Medicine, Massachusetts General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: maha_farhat@hms.harvard.edu ahaghighi@bwh.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

A multitude of demographic, health, and genetic factors are associated with the risk of developing severe COVID-19 following infection by the SARS-CoV-2. There is a need to perform studies across human societies and to investigate the full spectrum of genetic variation of the virus. Using data from 869 COVID-19 patients in Bahrain between March 2020 and March 2021, we analyzed paired viral sequencing and non-genetic host data to understand host and viral determinants of severe COVID-19. We estimated the effects of demographic variables specific to the Bahrain population and found that the impact of health factors are largely consistent with other populations. To extend beyond the common variants of concern in the Spike protein analyzed by previous studies, we used a viral burden approach and detected a protective effect of low-frequency missense viral mutations in the RNA-dependent RNA polymerase (Pol) gene on disease severity. Our results contribute to the survey of severe COVID-19 in diverse populations and highlight the benefits of studying rare viral mutations.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We would like to thank Luca Freschi for his assistance in the early stage of this project, as well as members of the Sunyaev lab for their constructive feedback. This study was funded by an award from the Bahrain Ministry of Health to AH (Fund #102075). AH was supported by the US National Heart, Lung, and Blood Institute (NHLBI K8HL150284), and the American Heart Association. EK and SH were supported by the US National Institutes of Health grant R35GM127131 to SH.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Mass General Brigham gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Typos were fixed, a duplicated paragraph was removed, and errors in the funding statement were fixed.

Data Availability

All data produced in the present study are available online at https://github.com/emkoch/CV19BH or upon request to the authors.

https://github.com/emkoch/CV19BH

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 30, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Demographic and Viral-Genetic Analyses of COVID-19 Severity in Bahrain Identify Local Risk Factors and a Protective Effect of Polymerase Mutations
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Demographic and Viral-Genetic Analyses of COVID-19 Severity in Bahrain Identify Local Risk Factors and a Protective Effect of Polymerase Mutations
Evan M. Koch, Justin Du, Michelle Dressner, Hashmeya Erahim Alwasti, Zahra Al Taif, Fatima Shehab, Afaf Merza Mohamed, Amjad Ghanem, Alireza Haghighi, Shamil Sunyaev, Maha Farhat
medRxiv 2022.08.13.22278740; doi: https://doi.org/10.1101/2022.08.13.22278740
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Demographic and Viral-Genetic Analyses of COVID-19 Severity in Bahrain Identify Local Risk Factors and a Protective Effect of Polymerase Mutations
Evan M. Koch, Justin Du, Michelle Dressner, Hashmeya Erahim Alwasti, Zahra Al Taif, Fatima Shehab, Afaf Merza Mohamed, Amjad Ghanem, Alireza Haghighi, Shamil Sunyaev, Maha Farhat
medRxiv 2022.08.13.22278740; doi: https://doi.org/10.1101/2022.08.13.22278740

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1434)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10330)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2653)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (681)
  • Hematology (269)
  • HIV/AIDS (570)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2483)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1333)
  • Ophthalmology (403)
  • Orthopedics (152)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2419)
  • Public and Global Health (5031)
  • Radiology and Imaging (901)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)